Fig. 9From: Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinomaChemical structures of the compounds that have been discussed in this article: Each compound structure was either generated using the ChemDraw Prime 16 software (Perkin Elmer) or downloaded from appropriate online sourcesBack to article page